Dr. Anusha Ganesh Govind, MD

Dr. Govind practices at Parkland Memorial Hospital in Dallas, Texas, part of Parkland Health.

Dr. Govind's NPI, 1710320551, was assigned on April 11, 2013. Dr. Govind graduated from Texas A&M College of Medicine - Bryan in 2013. Dr. Govind holds Texas license R8362.

Dr. Govind's primary practice is Parkland Memorial Hospital, at 5200 Harry Hines Blvd, Dallas, TX 75235 in Dallas County. The practice phone is (214) 590-8000.

Dr. Govind's primary practice is Parkland Memorial Hospital in Dallas, Texas, part of Parkland Health. Dr. Govind is also affiliated with William P. Clements Jr. University Hospital. The medical group on file is University of Texas Southwestern Medical Center. Dmand AI also links Dr. Govind to 1 more clinical lab and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Govind practices, 4 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Govind's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Govind is board certified in infectious disease by the American Board of Internal Medicine. Dmand AI has Dr. Govind's licenses on file in 2 states: Texas and Pennsylvania.

Dmand AI lists cirrhosis of the liver, depression, gout, heart failure, hiv/aids and tobacco use among the conditions Dr. Govind treats.

CMS data shows 56 Medicare services from Dr. Govind across 3 procedure codes in 2024, for 48 Medicare patients. Medicare paid $4,269 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 48 Medicare patients who saw Dr. Govind in 2024. The largest group is under 65, with 22 patients. 75% of them have high blood pressure, and 65% have high cholesterol. 44% are also on Medicaid. Their average risk score is 4.03, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Govind's median patient age at 53, with 28% women.

In 2024, Dr. Govind wrote 974 Medicare Part D claims for 70 patients. 68% of them were for generic drugs. CMS names the drug for 639 of them, across 23 drugs with 11 or more claims each, at $873,692 in total drug cost. In 2023, CMS named 647 claims across 25 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Govind for performance year 2024, reported as part of a group. Dr. Govind accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 7 papers to Dr. Govind, published from 2016 to 2019. 2017 was the busiest year, with 2. Dr. Govind has published most often in Case Rep Infect Dis. Dr. Govind's most frequent co-authors are Sanaa Somalya Arastu, MD, Jeremy Yan-Shun Chow, MD and Arturo Ricardo Dominguez, MD.

CMS Open Payments shows 8 general payments to Dr. Govind from 5 drug and device companies from 2017 to 2022. Food and beverage make up the largest share, 60% of the total. Astellas Pharma US Inc paid the most, $302.

Dmand AI lists 2 awards for Dr. Govind, most recently Certificate of completion in Primer on healthcare epidemiology, infection control, and antimicrobial stewardship: online course in 2016.

Dr. Govind graduated from Texas A&M College of Medicine - Bryan in 2013. Dr. Govind is a member of ACP, AMA and IDSA.

Dr. Govind is in network with 19 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.